Eli Reshef, MD

The Website of Eli Reshef, MD

  • Home
  • About
    • Dr. Reshef’s Bio
    • Why Choose Reshef?
  • FAQ
  • Educate Me!
    • Ectopic Pregnancy
    • Endometriosis
    • Egg Donation
    • Fibroids
    • Infertility
    • Insemination (Artificial)
    • In Vitro Fertilization
      • The IVF Journey
    • Male Factor Infertility
    • Menopause
    • Menstrual Disorders
    • Polycystic Ovarian Syndrome (POCS)
    • Recurrent Pregnancy Losses
    • Unexplained Infertility
  • Blog
    • Links
  • Contact
    • Directions
You are here: Home / Science and Research / Bad Business (or Don’t Mess with the Public)- the Makena Story

Bad Business (or Don’t Mess with the Public)- the Makena Story

September 4, 2012 By Eli Reshef

Eli Reshef MD

In February 2011, the FDA approved Makena for use in pregnant women to prevent premature labor. Premature delivery is a formidable health issue in the U.S., resulting in significant morbidity and mortality among babies and substantial health expenditure. Makena is the trade name given by its manufacturer, Ther-Rx, based in St. Louis, to a common form of progesterone injection called hydroxyprogesterone caproate (HPC).

HPC has been used for many years prior to its FDA approval for premature labor for other indications in pregnancy. A single injection cost $10-20. Upon approval of HPC, now known as Makena, by the FDA, Ther-Rx increased the cost of a single injection to $1500! This action sparked an outrage throughout the nation. Patients and physicians protested this price gouging via social, visual, and print media. In Oklahoma, we publicized the travesty on TV and newspapers; discouraged our colleagues from seeing Ther-Rx sales people; publicized available HPC from compounding pharmacies;  and urged March of Dimes and scientific publications to refuse doing business with Ther-Rx. Not only did Ther-Rx created an outrageous price increase that would make a common medication unaffordable to many, but it aggressively tried to block production of generic HPC by compounding pharmacies.

The national protest against Makena worked. Under congressional pressure, the FDA refused to ban production of generic, far less expensive HPC. Ther-Rx dropped the price per injection to $690 but the damage was already done. This was a monumental public relations nightmare to Ther-Rx, who saw its stock tumble from over $13 to under $1 per share. On August 4, 2012, Ther-Rx filed for Chapter 11 bankrupcy.

The Makena story is a classic example of the power of the public when health care professionals and patients band together for a common cause.

Related

  • Email
  • Facebook
  • YouTube

Meet Dr. Eli Reshef

The other day, another physician asked me if I had to start all over again, would I still become a physician and would I still choose Reproductive Endocrinology and Infertility as my sub-specialty. I answered with a resounding “yes”. I feel very fortunate to get up every morning looking forward to going to work. I feel privileged to have the opportunity to help people every day, that is every day, including weekends and holidays. Read More About Me Here-

Dr. Reshef's Most Popular Posts

  • Latest
  • Popular
  • Thousands of eggs, embryos possibly damaged at Ohio hospital
  • YOUR EMBRYOS ARE SAFE!
  • Employers Who Wish to Retain Staff Should Consider Having Infertility Benefit
  • Older Men’s Sperm: Worse for the Wear?
  • Subfertility May be Harbinger of Disease Later in Life
  • Today Week Month All
  • OKC Doctor: Planned Parenthood defunding would curtail reproductive care options
  • There is no "baby deadline" test!
  • Vitamin D Deficiency- Is There Really a Pandemic?
  • OKC doctor: Bashar al-Assad's ultimate betrayal of every physicians' oath
  • What You Really Need to Know About Egg Freezing
Ajax spinner

Post Archive

  • March 2018
  • October 2017
  • August 2017
  • March 2017
  • February 2017
  • January 2017
  • February 2016
  • January 2016
  • December 2015
  • October 2015
  • August 2015
  • July 2015
  • May 2015
  • April 2015
  • February 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • November 2013
  • October 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012

Contact Dr. Eli Reshef

  • We love people, not bots. Please select "Yes, I am Human" from the drop down below.

Recent Posts

  • Thousands of eggs, embryos possibly damaged at Ohio hospital
  • YOUR EMBRYOS ARE SAFE!
  • Employers Who Wish to Retain Staff Should Consider Having Infertility Benefit
  • Older Men’s Sperm: Worse for the Wear?
  • Subfertility May be Harbinger of Disease Later in Life
  • Repairing the Embryo: Successful Gene Editing to Repair Mutation in Human Haploid Cells
  • Email
  • Facebook
  • YouTube

Eli Reshef, MD

3433 NW 56th Street, Suite 210-B
Oklahoma CIty , OK 73112
Phone: (405) 945-4701

Post Calendar

December 2019
M T W T F S S
« Mar    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Copyright © 2019 · Eli Reshef, MD. All Rights Reserved.